Ownership history in UBS Group AG · 5 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in NLS PHARMACEUTICS LTD (NLSP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 38 | -14,944 | -99.7% | 0.00% | $70 | — |
| 2025 Q2 | REDUCED | 14,982 | -10,755 | -41.8% | 0.00% | $43K | — |
| 2025 Q1 | ADDED | 25,737 | +17,445 | +210.4% | 0.00% | $40K | — |
| 2024 Q4 | ADDED | 8,292 | +3,573 | +75.7% | 0.00% | $17K | — |
| 2024 Q3 | INITIATED | 4,719 | — | — | 0.00% | $24K | — |